NCT02223507View on ClinicalTrials.gov

Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

September 30, 2000

Conditions
Healthy
Interventions
DRUG

BIIR 561 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY